Inagaki, Mioka
Otsuka, Eriko
Hayashi, Yuko
Ohsawa, Masahiro
Hirano, Eiichi
Article History
Received: 1 October 2023
Accepted: 13 November 2023
First Online: 18 December 2023
Declarations
:
: This study was approved and reviewed by the Ethics Committee of Medical education i design lab (ID: A23-7-1). Informed consent was obtained from the study participant. Confidentiality was ensured. The study procedures were conducted in accordance with the Declaration of Helsinki and its amendments (Ethical Principles for Medical research Involving Human Subjects, adopted by the 18th World Medical Association General Assembly Helsinki, Finland, June 1964, and amendments).
: Written informed consent was obtained from the patient for the publication of this case report and the accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.
: Yuko Hayashi is a stockholder of WELLFIT Co., Ltd. Mioka Inagaki is an employee of WELLFIT Co., Ltd. Eriko Otsuka and Eiichi Hirano are employees of Japan Bio Products Co., Ltd. Masahiro Ohsawa declares no competing interests. This treatment was performed by WELLFIT Co., Ltd. for the monitors who paid for the purchase of the basalt stones and horse placenta extract required for the treatment. The cost of the treatment was borne by the monitors. The final manuscript was reviewed and approved by all authors. The authors did not receive any special gratuity or benefit.